Glucotrack Inc (GCTK)

$1.09 -0.01 (-0.46%)
Market Cap 1.10M
Revenue (ttm) 0.00
Net Income (ttm) -22.60M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 1.19
Volume 63,900
Avg Vol 407,078
Day's Range N/A - N/A
Shares Out 1.01M
Stochastic %K 13%
Beta 0.33
Analysts Strong Buy
Price Target N/A

Company Profile

GlucoTrack, Inc., a medical device company, focuses on the development of an implantable continuous blood glucose monitor (CBGM) for people with diabetes in the United States. The company develops the GlucoTrack, a non-invasive glucose monitoring device that helps people with diabetes and pre-diabetics to obtain blood glucose level readings without the pain through a small sensor clipped onto the earlobe. It is also developing the GlucoTrack CBGM, a long-term implantable blood-based CBGM for use...

Industry: Medical Instruments & Supplies
Sector: Healthcare
Phone: 201 842 7715
Address:
301 Route 17 North, Suite 800, Rutherford, United States
race2zero
race2zero Mar. 20 at 9:08 PM
$GCTK @FkDisManipulation i love beating someone into submission
1 · Reply
race2zero
race2zero Mar. 20 at 7:32 PM
$GCTK @FkDisManipulation blocked me! He talked all that smack and then ran away like a little bitch
0 · Reply
race2zero
race2zero Mar. 20 at 6:50 PM
$GCTK where are you? I really want you to see this go below $1 here very soon.
0 · Reply
race2zero
race2zero Mar. 20 at 12:25 PM
$GCTK I don’t think we will hear from @FkDisManipulation until next week. Most likely he is on a 72 hour hold
0 · Reply
race2zero
race2zero Mar. 20 at 12:22 AM
$GCTK a new all-time low today. Friday sell off tomorrow should easily take this under $1. Once it goes under $1, it isn’t coming back above without a RS
0 · Reply
VizTheWin
VizTheWin Mar. 19 at 11:25 PM
$GCTK it was a nice tax write off this year... bastards.
0 · Reply
race2zero
race2zero Mar. 19 at 11:23 PM
$GCTK did they finally come and take you away?
0 · Reply
race2zero
race2zero Mar. 19 at 11:06 PM
$GCTK did anything come out of the meeting?
0 · Reply
Deerslayer1998
Deerslayer1998 Mar. 19 at 10:44 PM
$GCTK you’re kidding me this is still dropping after a meeting in California. This is ridiculous
0 · Reply
race2zero
race2zero Mar. 19 at 5:03 PM
$GCTK dammit! It keeps getting worse for me. I don’t know why I got a Webull tax document in 2024….someone is messing with me. I shouldn’t have received this is I just opened my account a couple of days ago, right?
0 · Reply
Latest News on GCTK
Glucotrack to Present at LSI USA '26 Medtech Innovation Summit

Mar 10, 2026, 8:01 AM EDT - 11 days ago

Glucotrack to Present at LSI USA '26 Medtech Innovation Summit

Glucotrack Announces USPTO Approval for Issuance of Patents for Proprietary CBGM Platform

Jan 29, 2026, 8:01 AM EST - 7 weeks ago

Glucotrack Announces USPTO Approval for Issuance of Patents for Proprietary CBGM Platform

Glucotrack, Inc. Announces Pricing of $4.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules with a Single Institutional Investor

Dec 30, 2025, 8:00 AM EST - 2 months ago

Glucotrack, Inc. Announces Pricing of $4.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules with a Single Institutional Investor

Glucotrack Reports Third Quarter 2025 Financial Results and Provides Update on Recent Corporate Highlights

Nov 13, 2025, 4:05 PM EST - 4 months ago

Glucotrack Reports Third Quarter 2025 Financial Results and Provides Update on Recent Corporate Highlights

Glucotrack, Inc. Encourages Shareholders to Vote

Nov 3, 2025, 4:05 PM EST - 4 months ago

Glucotrack, Inc. Encourages Shareholders to Vote

Glucotrack Appoints Neuromodulation and Painful Diabetic Neuropathy Expert, Usman Latif, MD, MBA, to Clinical Advisory Team

Oct 29, 2025, 4:05 PM EDT - 5 months ago

Glucotrack Appoints Neuromodulation and Painful Diabetic Neuropathy Expert, Usman Latif, MD, MBA, to Clinical Advisory Team

Glucotrack, Inc. Reminds Shareholders to Vote

Oct 28, 2025, 8:00 AM EDT - 5 months ago

Glucotrack, Inc. Reminds Shareholders to Vote

Glucotrack to Participate in the Q3 Virtual Investor Summit

Sep 11, 2025, 8:00 AM EDT - 6 months ago

Glucotrack to Participate in the Q3 Virtual Investor Summit

Glucotrack Reports Second Quarter 2025 Financial Results and Recent Corporate Highlights

Aug 14, 2025, 4:05 PM EDT - 7 months ago

Glucotrack Reports Second Quarter 2025 Financial Results and Recent Corporate Highlights

Glucotrack Expands Clinical Advisory Team Appointing David S. Hirsh, MD as Medical Director, Cardiology

Aug 6, 2025, 8:30 AM EDT - 8 months ago

Glucotrack Expands Clinical Advisory Team Appointing David S. Hirsh, MD as Medical Director, Cardiology

Glucotrack to Exhibit at 2025 Association of Diabetes Care and Education Specialists Annual Meeting

Jul 31, 2025, 8:30 AM EDT - 8 months ago

Glucotrack to Exhibit at 2025 Association of Diabetes Care and Education Specialists Annual Meeting

Glucotrack Announces Repurchase of Series A Warrants

Jul 8, 2025, 8:30 AM EDT - 9 months ago

Glucotrack Announces Repurchase of Series A Warrants

Why Is This Nano-Cap Glucotrack Stock Trading Higher On Wednesday?

Jun 25, 2025, 10:40 AM EDT - 9 months ago

Why Is This Nano-Cap Glucotrack Stock Trading Higher On Wednesday?

Glucotrack and OneTwo Analytics Present Positive Final Results of First-In-Human Study for Continuous Blood Glucose Monitor at American Diabetes Association's 85th Scientific Sessions

Jun 25, 2025, 8:30 AM EDT - 9 months ago

Glucotrack and OneTwo Analytics Present Positive Final Results of First-In-Human Study for Continuous Blood Glucose Monitor at American Diabetes Association's 85th Scientific Sessions

Glucotrack Announces Reverse Stock Split Shareholder Approved Action Meets NASDAQ Panel Hearing Listing Requirements

Jun 12, 2025, 9:05 AM EDT - 10 months ago

Glucotrack Announces Reverse Stock Split Shareholder Approved Action Meets NASDAQ Panel Hearing Listing Requirements

Glucotrack to Showcase Long-Term Continuous Blood Glucose Monitor at American Diabetes Association's 85th Scientific Sessions

Jun 4, 2025, 8:30 AM EDT - 10 months ago

Glucotrack to Showcase Long-Term Continuous Blood Glucose Monitor at American Diabetes Association's 85th Scientific Sessions

Glucotrack Strengthens Board of Directors with Election of Victoria E. Carr-Brendel, PhD

May 28, 2025, 8:30 AM EDT - 10 months ago

Glucotrack Strengthens Board of Directors with Election of Victoria E. Carr-Brendel, PhD

Glucotrack Establishes Patient Advisory Board to Inform Diabetes Technology Development

May 20, 2025, 8:30 AM EDT - 10 months ago

Glucotrack Establishes Patient Advisory Board to Inform Diabetes Technology Development

Glucotrack Reports First Quarter 2025 Financial Results and Recent Corporate Highlights

May 14, 2025, 5:10 PM EDT - 11 months ago

Glucotrack Reports First Quarter 2025 Financial Results and Recent Corporate Highlights

Glucotrack Announces Ethical Approval for Long-Term Clinical Study of Continuous Blood Glucose Monitor

May 13, 2025, 8:01 AM EDT - 11 months ago

Glucotrack Announces Ethical Approval for Long-Term Clinical Study of Continuous Blood Glucose Monitor

Glucotrack to Participate in FORGETDIABETES, a Prominent European Research Initiative to Develop a Bionic Pancreas

Apr 16, 2025, 8:00 AM EDT - 1 year ago

Glucotrack to Participate in FORGETDIABETES, a Prominent European Research Initiative to Develop a Bionic Pancreas

Glucotrack and OneTwo Analytics to Collaborate for Clinical Study Analysis on Its Continuous Blood Glucose Monitor

Apr 3, 2025, 8:01 AM EDT - 1 year ago

Glucotrack and OneTwo Analytics to Collaborate for Clinical Study Analysis on Its Continuous Blood Glucose Monitor

Glucotrack Reports Full Year 2024 Financial Results and Recent Corporate Highlights

Mar 31, 2025, 5:00 PM EDT - 1 year ago

Glucotrack Reports Full Year 2024 Financial Results and Recent Corporate Highlights

Glucotrack to Present First-In-Human Study Results for Continuous Blood Glucose Monitor at the 2025 International Conference on Advanced Technologies & Treatment for Diabetes

Mar 19, 2025, 8:01 AM EDT - 1 year ago

Glucotrack to Present First-In-Human Study Results for Continuous Blood Glucose Monitor at the 2025 International Conference on Advanced Technologies & Treatment for Diabetes

Glucotrack Appoints Guillermo Umpierrez, MD, CDCES, FACE, MACP as New Medical Advisory Board Member

Feb 26, 2025, 8:01 AM EST - 1 year ago

Glucotrack Appoints Guillermo Umpierrez, MD, CDCES, FACE, MACP as New Medical Advisory Board Member

Glucotrack, Inc. Announces Pricing of $3.0 Million Public Offering

Feb 4, 2025, 12:24 PM EST - 1 year ago

Glucotrack, Inc. Announces Pricing of $3.0 Million Public Offering

Glucotrack Announces Successful Completion of Its First Human Clinical Study of Continuous Blood Glucose Monitor

Feb 4, 2025, 8:01 AM EST - 1 year ago

Glucotrack Announces Successful Completion of Its First Human Clinical Study of Continuous Blood Glucose Monitor

Glucotrack Strengthens Leadership Team with Appointment of New Chief Financial Officer

Jan 29, 2025, 9:00 AM EST - 1 year ago

Glucotrack Strengthens Leadership Team with Appointment of New Chief Financial Officer

Glucotrack Announces ISO 13485:2016 Certification

Jan 21, 2025, 8:01 AM EST - 1 year ago

Glucotrack Announces ISO 13485:2016 Certification

Glucotrack Strenghtens Leadership Team with Addition of Industry Veteran as Vice President of Regulatory Affairs

Jan 15, 2025, 8:01 AM EST - 1 year ago

Glucotrack Strenghtens Leadership Team with Addition of Industry Veteran as Vice President of Regulatory Affairs

Glucotrack to Present at TechBio Showcase™ 2025

Jan 7, 2025, 4:05 PM EST - 1 year ago

Glucotrack to Present at TechBio Showcase™ 2025

GLUCOTRACK ANNOUNCES START OF ENROLLMENT FOR HUMAN CLINICAL STUDY OF CONTINUOUS BLOOD GLUCOSE MONITOR

Dec 3, 2024, 8:30 AM EST - 1 year ago

GLUCOTRACK ANNOUNCES START OF ENROLLMENT FOR HUMAN CLINICAL STUDY OF CONTINUOUS BLOOD GLUCOSE MONITOR

Glucotrack, Inc. Announces Closing of $10.0 Million Public Offering and Concurrent Private Placement Converting $4.0 in Outstanding Debt

Nov 14, 2024, 4:30 PM EST - 1 year ago

Glucotrack, Inc. Announces Closing of $10.0 Million Public Offering and Concurrent Private Placement Converting $4.0 in Outstanding Debt

GLUCOTRACK TO PRESENT AT 2024 BIOFUTURE CONFERENCE

Oct 22, 2024, 9:00 AM EDT - 1 year ago

GLUCOTRACK TO PRESENT AT 2024 BIOFUTURE CONFERENCE

GLUCOTRACK ANNOUNCES ORAL & POSTER PRESENTATIONS AT THE 2024 DIABETES TECHNOLOGY MEETING

Oct 1, 2024, 9:00 AM EDT - 1 year ago

GLUCOTRACK ANNOUNCES ORAL & POSTER PRESENTATIONS AT THE 2024 DIABETES TECHNOLOGY MEETING

JOHN BALLANTYNE, FORMER BIOTECHNOLOGY EXECUTIVE, JOINS THE GLUCOTRACK BOARD OF DIRECTORS

Sep 3, 2024, 9:00 AM EDT - 1 year ago

JOHN BALLANTYNE, FORMER BIOTECHNOLOGY EXECUTIVE, JOINS THE GLUCOTRACK BOARD OF DIRECTORS

Glucotrack's Innovative Blood Glucose Monitoring Concept Resonates with Patients with Diabetes, According to New Survey Presented at Association of Diabetes Care and Education Specialists (ADCES) 2024 Annual Conference

Aug 15, 2024, 9:00 AM EDT - 1 year ago

Glucotrack's Innovative Blood Glucose Monitoring Concept Resonates with Patients with Diabetes, According to New Survey Presented at Association of Diabetes Care and Education Specialists (ADCES) 2024 Annual Conference

GLUCOTRACK ANNOUNCES POSTER PRESENTATION ON CONTINUOUS BLOOD GLUCOSE MONITOR SURVEY DATA AT THE ASSOCIATION OF DIABETES CARE AND EDUCATION SPECIALISTS (ADCES) 2024 ANNUAL CONFERENCE

Aug 5, 2024, 9:00 AM EDT - 1 year ago

GLUCOTRACK ANNOUNCES POSTER PRESENTATION ON CONTINUOUS BLOOD GLUCOSE MONITOR SURVEY DATA AT THE ASSOCIATION OF DIABETES CARE AND EDUCATION SPECIALISTS (ADCES) 2024 ANNUAL CONFERENCE

GLUCOTRACK ANNOUNCES THE APPOINTMENT OF ANDY BALO TO BOARD OF DIRECTORS

Jun 20, 2024, 8:30 AM EDT - 1 year ago

GLUCOTRACK ANNOUNCES THE APPOINTMENT OF ANDY BALO TO BOARD OF DIRECTORS

GLUCOTRACK REPORTS SUCCESSFUL COMPLETION OF FIRST REPORTED LONG-TERM PRECLINICAL STUDY OF ITS EPIDURAL GLUCOSE MONITORING SENSOR

Jun 13, 2024, 9:19 AM EDT - 1 year ago

GLUCOTRACK REPORTS SUCCESSFUL COMPLETION OF FIRST REPORTED LONG-TERM PRECLINICAL STUDY OF ITS EPIDURAL GLUCOSE MONITORING SENSOR

GLUCOTRACK TO PRESENT IN THE JUNE 2024 SIDOTI SMALL CAP CONFERENCE

Jun 10, 2024, 10:50 AM EDT - 1 year ago

GLUCOTRACK TO PRESENT IN THE JUNE 2024 SIDOTI SMALL CAP CONFERENCE

GLUCOTRACK ANNOUNCES 90-DAY PRECLINICAL STUDY RESULTS THAT DEMONSTRATE SUSTAINED ACCURACY OF ITS IMPLANTABLE CONTINUOUS BLOOD GLUCOSE MONITOR

Jun 5, 2024, 8:30 AM EDT - 1 year ago

GLUCOTRACK ANNOUNCES 90-DAY PRECLINICAL STUDY RESULTS THAT DEMONSTRATE SUSTAINED ACCURACY OF ITS IMPLANTABLE CONTINUOUS BLOOD GLUCOSE MONITOR

GLUCOTRACK'S EPIDURAL GLUCOSE MONITORING SENSOR DEMONSTRATES SUCCESSFUL 30-DAY SAFETY & PERFORMANCE IN LONG-TERM PRECLINICAL STUDY

May 16, 2024, 8:30 AM EDT - 2 years ago

GLUCOTRACK'S EPIDURAL GLUCOSE MONITORING SENSOR DEMONSTRATES SUCCESSFUL 30-DAY SAFETY & PERFORMANCE IN LONG-TERM PRECLINICAL STUDY

GLUCOTRACK ANNOUNCES REVERSE STOCK SPLIT

May 15, 2024, 4:15 PM EDT - 2 years ago

GLUCOTRACK ANNOUNCES REVERSE STOCK SPLIT

GLUCOTRACK ANNOUNCES ABSTRACTS ACCEPTED FOR POSTER PRESENTATION AT 84TH SCIENTIFIC SESSIONS OF THE AMERICAN DIABETES ASSOCIATION

May 2, 2024, 9:00 AM EDT - 2 years ago

GLUCOTRACK ANNOUNCES ABSTRACTS ACCEPTED FOR POSTER PRESENTATION AT 84TH SCIENTIFIC SESSIONS OF THE AMERICAN DIABETES ASSOCIATION

GLUCOTRACK ANNOUNCES CLOSING OF PRIVATE PLACEMENT

Apr 22, 2024, 2:10 PM EDT - 2 years ago

GLUCOTRACK ANNOUNCES CLOSING OF PRIVATE PLACEMENT

GLUCOTRACK ANNOUNCES EXPANSION OF ITS CONTINUOUS GLUCOSE MONITORING TECHNOLOGY TO EPIDURAL GLUCOSE MONITORING

Apr 16, 2024, 8:30 AM EDT - 2 years ago

GLUCOTRACK ANNOUNCES EXPANSION OF ITS CONTINUOUS GLUCOSE MONITORING TECHNOLOGY TO EPIDURAL GLUCOSE MONITORING

GLUCOTRACK ANNOUNCES INCREASED SENSOR LONGEVITY FOR ITS IMPLANTABLE CONTINUOUS BLOOD GLUCOSE MONITOR

Apr 2, 2024, 8:30 AM EDT - 2 years ago

GLUCOTRACK ANNOUNCES INCREASED SENSOR LONGEVITY FOR ITS IMPLANTABLE CONTINUOUS BLOOD GLUCOSE MONITOR

GLUCOTRACK EXPANDS LEADERSHIP TEAM WITH NEW VICE PRESIDENT OF QUALITY

Mar 12, 2024, 9:30 AM EDT - 2 years ago

GLUCOTRACK EXPANDS LEADERSHIP TEAM WITH NEW VICE PRESIDENT OF QUALITY

GLUCOTRACK SELECTS CIRTEC MEDICAL AS MANUFACTURER FOR ITS IMPLANTABLE CONTINUOUS BLOOD GLUCOSE MONITOR

Feb 27, 2024, 8:30 AM EST - 2 years ago

GLUCOTRACK SELECTS CIRTEC MEDICAL AS MANUFACTURER FOR ITS IMPLANTABLE CONTINUOUS BLOOD GLUCOSE MONITOR

race2zero
race2zero Mar. 20 at 9:08 PM
$GCTK @FkDisManipulation i love beating someone into submission
1 · Reply
race2zero
race2zero Mar. 20 at 7:32 PM
$GCTK @FkDisManipulation blocked me! He talked all that smack and then ran away like a little bitch
0 · Reply
race2zero
race2zero Mar. 20 at 6:50 PM
$GCTK where are you? I really want you to see this go below $1 here very soon.
0 · Reply
race2zero
race2zero Mar. 20 at 12:25 PM
$GCTK I don’t think we will hear from @FkDisManipulation until next week. Most likely he is on a 72 hour hold
0 · Reply
race2zero
race2zero Mar. 20 at 12:22 AM
$GCTK a new all-time low today. Friday sell off tomorrow should easily take this under $1. Once it goes under $1, it isn’t coming back above without a RS
0 · Reply
VizTheWin
VizTheWin Mar. 19 at 11:25 PM
$GCTK it was a nice tax write off this year... bastards.
0 · Reply
race2zero
race2zero Mar. 19 at 11:23 PM
$GCTK did they finally come and take you away?
0 · Reply
race2zero
race2zero Mar. 19 at 11:06 PM
$GCTK did anything come out of the meeting?
0 · Reply
Deerslayer1998
Deerslayer1998 Mar. 19 at 10:44 PM
$GCTK you’re kidding me this is still dropping after a meeting in California. This is ridiculous
0 · Reply
race2zero
race2zero Mar. 19 at 5:03 PM
$GCTK dammit! It keeps getting worse for me. I don’t know why I got a Webull tax document in 2024….someone is messing with me. I shouldn’t have received this is I just opened my account a couple of days ago, right?
0 · Reply
FkDisManipulation
FkDisManipulation Mar. 19 at 4:42 PM
$GCTK smelly midget u r a low caliber RobinHooder n u just downloaded Webull AFTER i mocked ur fgt ass u cant short shit not 1 dollar per day making CkSkr ur a POSER
0 · Reply
race2zero
race2zero Mar. 19 at 4:05 PM
$GCTK any real player has multiple accounts and multiple platforms, tell me you don’t know anything without telling me you don’t know anything.
0 · Reply
anonAlb
anonAlb Mar. 19 at 3:22 PM
$GCTK we need to hold the line bulls until the news 🫡
0 · Reply
race2zero
race2zero Mar. 19 at 3:06 PM
$GCTK oh good, I didn’t realize that. That means my price target of .50 is still in play. Phew, that was close. @The_Sophisticate
1 · Reply
race2zero
race2zero Mar. 19 at 2:31 PM
$GCTK finally someone else in here with some brains
1 · Reply
The_Sophisticate
The_Sophisticate Mar. 19 at 2:29 PM
$GCTK order book suggests bottom will be 0.75-0.85 range. but who knows when the market is controlled by psychopaths...
0 · Reply
race2zero
race2zero Mar. 19 at 1:59 PM
$GCTK looks like it wants to fly today
0 · Reply
race2zero
race2zero Mar. 19 at 1:25 PM
$GCTK you are so impatient, I told you, I hope to get to all of that this weekend
0 · Reply
race2zero
race2zero Mar. 19 at 1:17 PM
$GCTK you mean all my short positions have been fake? Dammit! I thought I was making money….now I’m sad
1 · Reply
FkDisManipulation
FkDisManipulation Mar. 19 at 1:15 PM
$GCTK this pathetic fkn fgt lost money ans now lost his mind This sht race fgt can't even open short position but the midget fgt spamming all day
0 · Reply
race2zero
race2zero Mar. 19 at 12:57 PM
$GCTK good morning sunshine, going to be a beautiful day
0 · Reply
FkDisManipulation
FkDisManipulation Mar. 19 at 12:45 PM
$GCTK $UOKA $CLDI $UOKA Short? You pathetic lil midget you use RobinHood, tell us again how you opened that magical short position you fraud ass spamming retard
1 · Reply